VC-backed Trevena files for IPO: CORRECTED
Trevana said Thursday that it has filed for an IPO. The number of shares and pricing terms have yet to be decided. Trevana plans on trading the stock on the NASDAQ under the ticker symbol "TRVN." Barclays Capital and Jefferies are serving as lead underwriters. Based in King of Prussia, Penn., Trevena is a clinical stage biopharmaceutical company that develops therapeutics that G protein coupled receptors. It is backed by Alta Partners, New Enterprise Associates, Polaris Partners, Forest Labs and HealthCare Ventures.
10 October 2013•2 mins read
